{"database": "lobbying", "table": "lobbying_activities", "rows": [[2512819, "cb6701a2-6491-4ed0-a28b-f1bd306d95e8", "Q3", "PUBLIC CITIZEN", 32362, "PUBLIC CITIZEN", 2020, "third_quarter", "PHA", "H.R. 7296 (MMAPPP Act); H.R. 7288 (TRACK Act); Patents for Humanity Program Improvement Act; transparency for federally support covid R&D; covid-19 medicine pricing and access, Drug pricing, Covid 19 Medicine pricing, manufacture and access,", "HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE", null, 100000, 0, 0, "2020-10-17T14:48:09.177000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2512819"], "units": {}, "query_ms": 0.4161270335316658, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}